Clinical Trial Update: n-3 Polyunsaturated Fatty Acids in Obesity [Phase 2]

View source ↗

Summary

Phase 2 study evaluating omega-3 polyunsaturated fatty acids in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adipose Tissue Inflammation
• Morbid Obesity

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Medical University of Vienna | Conditions: Adipose Tissue Inflammation, Morbid Obesity | Phase 2 | Status: COMPLETED